These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33532634)

  • 1. Statistical fundamentals on cancer research for clinicians: Working with your statisticians.
    Xu W; Huang SH; Su J; Gudi S; O'Sullivan B
    Clin Transl Radiat Oncol; 2021 Mar; 27():75-84. PubMed ID: 33532634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop.
    Totton N; Julious SA; Coates E; Hughes DA; Cook JA; Biggs K; Hewitt C; Day S; Cook A
    Health Technol Assess; 2023 Oct; 27(20):1-58. PubMed ID: 37982521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of antibacterial agents: a practical guide to design and analysis. Statisticians in the Pharmaceutical Industry Working Party.
    Smith C; Burley C; Ireson M; Johnson T; Jordan D; Knight S; Mason T; Massey D; Moss J; Williams K
    J Antimicrob Chemother; 1998 Apr; 41(4):467-80. PubMed ID: 9598778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority and non-inferiority: two sides of the same coin?
    Dunn DT; Copas AJ; Brocklehurst P
    Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs.
    Linde M; van Ravenzwaaij D
    BMC Med Res Methodol; 2023 Nov; 23(1):279. PubMed ID: 38001458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-inferiority trials in cardiology: what clinicians need to know.
    Leung JT; Barnes SL; Lo ST; Leung DY
    Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing superiority at interim analyses in a non-inferiority trial.
    Chen YH; Chen C
    Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage adaptive strategy for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Shih WJ; Quan H; Li G
    Stat Med; 2004 Sep; 23(18):2781-98. PubMed ID: 15344186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer.
    Sampayo-Cordero M; Miguel-Huguet B; Malfettone A; López-Miranda E; Gion M; Abad E; Alcalá-López D; Pérez-Escuredo J; Pérez-García JM; Llombart-Cussac A; Cortés J
    Front Oncol; 2023; 13():1048242. PubMed ID: 37496662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical guide to sample size calculations: non-inferiority and equivalence trials.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):80-9. PubMed ID: 26604186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing two variances for superiority/non-inferiority and equivalence: Using the exhaustion algorithm for sample size allocation with cost.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2020 May; 73(2):316-332. PubMed ID: 31190402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.